PT90722A - Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina - Google Patents

Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina

Info

Publication number: PT90722A
Authority: PT; Portugal
Prior art keywords: alkylxxine; preparing; dosage based; dosage form; controlled liberation
Prior art date: 1988-06-02

Application number

PT90722A

Other languages

English (en)

Other versions

PT90722B (pt

Inventor

Joanne Heafield

Sandra Therese Antoi Malkowska

Original Assignee

Euro Celtique Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-06-02

Filing date

1989-06-01

Publication date

1989-12-29

1989-06-01 Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa

1989-12-29 Publication of PT90722A publication Critical patent/PT90722A/pt

1994-11-30 Publication of PT90722B publication Critical patent/PT90722B/pt

Links

XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 3
239000002552 dosage form Substances 0.000 abstract 2
ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 abstract 2
238000013270 controlled release Methods 0.000 abstract 1
229920001477 hydrophilic polymer Polymers 0.000 abstract 1
229920001600 hydrophobic polymer Polymers 0.000 abstract 1
230000008018 melting Effects 0.000 abstract 1
238000002844 melting Methods 0.000 abstract 1
239000006186 oral dosage form Substances 0.000 abstract 1
239000007787 solid Substances 0.000 abstract 1
229960000278 theophylline Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PT90722A 1988-06-02 1989-06-01 Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina PT90722B (pt)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB888813064A GB8813064D0 (en)	1988-06-02	1988-06-02	Controlled release dosage forms having defined water content

Publications (2)

Publication Number	Publication Date
PT90722A true PT90722A (pt)	1989-12-29
PT90722B PT90722B (pt)	1994-11-30

Family

ID=10637952

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PT90722A PT90722B (pt)	1988-06-02	1989-06-01	Processo de preparacao de uma forma de dosagem de libertacao controlada a base de uma 3-alquilxantina

Country Status (19)

Country	Link
US (1)	US5091189A (pt)
EP (1)	EP0344960B1 (pt)
JP (1)	JPH0816060B2 (pt)
KR (1)	KR0136279B1 (pt)
AT (1)	ATE83925T1 (pt)
AU (1)	AU610401B2 (pt)
CA (1)	CA1323834C (pt)
DE (1)	DE68904119T2 (pt)
DK (1)	DK175130B1 (pt)
ES (1)	ES2053989T3 (pt)
FI (1)	FI93695C (pt)
GB (2)	GB8813064D0 (pt)
GR (1)	GR3007088T3 (pt)
IE (1)	IE61998B1 (pt)
IL (1)	IL90462A (pt)
NO (1)	NO176232C (pt)
NZ (1)	NZ229372A (pt)
PT (1)	PT90722B (pt)
ZA (1)	ZA894201B (pt)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6262115B1 (en) *	1995-05-22	2001-07-17	Alza Coporation	Method for the management of incontinence
US5912268A (en) *	1995-05-22	1999-06-15	Alza Corporation	Dosage form and method for treating incontinence
DK1685839T3 (da)	1997-12-22	2013-06-24	Euro Celtique Sa	Farmaceutisk oral doseringsform omfattende en kombination af en opioidagonist og opioidantagonist
CN1204890C (zh) *	1997-12-22	2005-06-08	欧罗赛铁克股份有限公司	防止阿片样物质滥用的方法
AU1738800A (en)	1998-11-23	2000-06-13	Bonnie Davis	Dosage formulations for acetylcholinesterase inhibitors
AU776666B2 (en)	2000-02-08	2004-09-16	Euro-Celtique S.A.	Tamper-resistant oral opioid agonist formulations
CN1525851A (zh)	2001-05-11	2004-09-01	��ҩ��޹�˾	抗滥用阿片样物质控释剂型
US7052706B2 (en) *	2001-06-08	2006-05-30	Nostrum Pharmaceuticals, Inc.	Control release formulation containing a hydrophobic material as the sustained release agent
US7943173B2 (en) *	2001-07-18	2011-05-17	Purdue Pharma L.P.	Pharmaceutical combinations of oxycodone and naloxone
US20030044458A1 (en) *	2001-08-06	2003-03-06	Curtis Wright	Oral dosage form comprising a therapeutic agent and an adverse-effect agent
US20030157168A1 (en) *	2001-08-06	2003-08-21	Christopher Breder	Sequestered antagonist formulations
WO2003013525A1 (en)	2001-08-06	2003-02-20	Euro-Celtique S.A.	Opioid agonist formulations with releasable and sequestered antagonist
IN192180B (pt) *	2001-09-28	2004-03-06	Ranbaxy Lab
CA2479350A1 (en) *	2002-03-15	2003-09-25	Cypress Bioscience, Inc.	Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
CA2478515C (en)	2002-04-05	2010-09-28	Purdue Pharma	Pharmaceutical preparation containing oxycodone and naloxone
DK1551372T3 (en)	2002-09-20	2018-07-23	Alpharma Pharmaceuticals Llc	SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
US20060003004A1 (en) *	2002-10-25	2006-01-05	Collegium Pharmaceutical, Inc.	Pulsatile release compositions of milnacipran
US20040132826A1 (en) *	2002-10-25	2004-07-08	Collegium Pharmaceutical, Inc.	Modified release compositions of milnacipran
JP2006515008A (ja) *	2003-01-28	2006-05-18	コレギウムファーマシューティカル，インコーポレイテッド	経口投与のためのミルナシプランの多粒子状組成物
US20040202717A1 (en) *	2003-04-08	2004-10-14	Mehta Atul M.	Abuse-resistant oral dosage forms and method of use thereof
TWI347201B (en) *	2003-04-21	2011-08-21	Euro Celtique Sa	Pharmaceutical products,uses thereof and methods for preparing the same
EP1604666A1 (en) *	2004-06-08	2005-12-14	Euro-Celtique S.A.	Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
EA012220B1 (ru) *	2004-10-19	2009-08-28	Крка, Товарна Здравил, Д. Д., Ново Место	Твёрдая фармацевтическая композиция, содержащая донепезила гидрохлорид
EP1702558A1 (en) *	2005-02-28	2006-09-20	Euro-Celtique S.A.	Method and device for the assessment of bowel function
ZA200802602B (en) *	2005-08-24	2009-10-28	Rubicon Res Pvt Ltd	Controlled release formulation
KR101486228B1 (ko) *	2006-06-19	2015-01-26	알파마 파머슈티컬스 엘엘씨	약제학적 조성물
CA2662358C (en) *	2006-09-29	2015-02-10	The Procter & Gamble Company	Oral compositions containing gel networks
US20100151014A1 (en) *	2008-12-16	2010-06-17	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
AU2008346870A1 (en) *	2007-12-17	2009-07-16	Alpharma Pharmaceuticals, Llc	Pharmaceutical composition
US8623418B2 (en) *	2007-12-17	2014-01-07	Alpharma Pharmaceuticals Llc	Pharmaceutical composition
KR20130105935A (ko) *	2008-07-07	2013-09-26	유로-셀티큐 에스.에이.	요폐의 치료를 위한 아편유사제 길항제의 용도
WO2010103039A1 (en)	2009-03-10	2010-09-16	Euro-Celtique S.A.	Immediate release pharmaceutical compositions comprising oxycodone and naloxone
KR20180037074A (ko)	2013-07-23	2018-04-10	유로-셀티큐 에스.에이.	장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
CN114053235B (zh) *	2020-08-07	2023-07-18	广州白云山光华制药股份有限公司	茶碱缓释片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3965256A (en) *	1972-05-16	1976-06-22	Synergistics	Slow release pharmaceutical compositions
US4443428A (en) *	1982-06-21	1984-04-17	Euroceltique, S.A.	Extended action controlled release compositions
FR2535202B1 (fr) *	1982-11-03	1985-08-09	Fabre Sa Pierre	Comprimes de theophylline a liberation controlee et leur procede de fabrication
US4743247A (en) *	1984-08-13	1988-05-10	Alza Corporation	Process for manufacturing dosage form
US4753800A (en) *	1985-10-04	1988-06-28	Warner-Lambert Company	Medicament adsorbates and their preparation
US4892742A (en) *	1985-11-18	1990-01-09	Hoffmann-La Roche Inc.	Controlled release compositions with zero order release
GB8613688D0 (en) *	1986-06-05	1986-07-09	Euro Celtique Sa	Pharmaceutical composition
ES2058111T3 (es) *	1986-06-10	1994-11-01	Euro Celtique Sa	Composicion de liberacion controlada de dihidrocodeina.
GB8626098D0 (en) *	1986-10-31	1986-12-03	Euro Celtique Sa	Controlled release hydromorphone composition
GB8628728D0 (en) *	1986-12-02	1987-01-07	Euro Celtique Sa	Spheroids

1988
- 1988-06-02 GB GB888813064A patent/GB8813064D0/en active Pending
1989
- 1989-05-19 GB GB8911629A patent/GB2219207B/en not_active Expired - Fee Related
- 1989-05-23 ES ES89305209T patent/ES2053989T3/es not_active Expired - Lifetime
- 1989-05-23 AT AT89305209T patent/ATE83925T1/de not_active IP Right Cessation
- 1989-05-23 EP EP89305209A patent/EP0344960B1/en not_active Expired - Lifetime
- 1989-05-23 DE DE8989305209T patent/DE68904119T2/de not_active Expired - Lifetime
- 1989-05-24 AU AU35127/89A patent/AU610401B2/en not_active Expired
- 1989-05-29 CA CA000600949A patent/CA1323834C/en not_active Expired - Lifetime
- 1989-05-30 IL IL90462A patent/IL90462A/xx unknown
- 1989-05-31 NZ NZ229372A patent/NZ229372A/en unknown
- 1989-06-01 DK DK198902668A patent/DK175130B1/da not_active IP Right Cessation
- 1989-06-01 NO NO892229A patent/NO176232C/no not_active IP Right Cessation
- 1989-06-01 FI FI892664A patent/FI93695C/fi active IP Right Grant
- 1989-06-01 PT PT90722A patent/PT90722B/pt not_active IP Right Cessation
- 1989-06-01 KR KR1019890007506A patent/KR0136279B1/ko not_active Expired - Lifetime
- 1989-06-01 JP JP1140229A patent/JPH0816060B2/ja not_active Expired - Lifetime
- 1989-06-02 ZA ZA894201A patent/ZA894201B/xx unknown
- 1989-06-12 IE IE174489A patent/IE61998B1/en not_active IP Right Cessation
1991
- 1991-05-17 US US07/704,714 patent/US5091189A/en not_active Expired - Lifetime
1993
- 1993-02-17 GR GR930400321T patent/GR3007088T3/el unknown

Also Published As

Publication number	Publication date
JPH0816060B2 (ja)	1996-02-21
IL90462A0 (en)	1990-01-18
NO176232C (no)	1995-03-01
EP0344960A3 (en)	1990-03-07
ES2053989T3 (es)	1994-08-01
GB8813064D0 (en)	1988-07-06
GB2219207A (en)	1989-12-06
KR0136279B1 (ko)	1998-04-25
CA1323834C (en)	1993-11-02
NO892229D0 (no)	1989-06-01
DK266889A (da)	1989-12-03
DE68904119D1 (de)	1993-02-11
IL90462A (en)	1993-01-31
GR3007088T3 (pt)	1993-07-30
IE61998B1 (en)	1994-12-14
FI93695B (fi)	1995-02-15
IE891744L (en)	1989-12-02
DE68904119T2 (de)	1993-06-09
EP0344960B1 (en)	1992-12-30
NO892229L (no)	1989-12-04
PT90722B (pt)	1994-11-30
DK175130B1 (da)	2004-06-14
GB2219207B (en)	1992-01-02
DK266889D0 (da)	1989-06-01
JPH0225420A (ja)	1990-01-26
FI93695C (fi)	1995-05-26
FI892664L (fi)	1989-12-03
ZA894201B (en)	1990-03-28
AU610401B2 (en)	1991-05-16
KR900000077A (ko)	1990-01-30
US5091189A (en)	1992-02-25
GB8911629D0 (en)	1989-07-05
ATE83925T1 (de)	1993-01-15
FI892664A0 (fi)	1989-06-01
AU3512789A (en)	1989-12-07
NZ229372A (en)	1991-07-26
NO176232B (no)	1994-11-21
EP0344960A2 (en)	1989-12-06

Legal Events

Date

Code

Title

Description

1994-11-30

FG3A

Patent granted, date of granting

Effective date: 19940516

2009-06-09

MM4A

Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090601

Publication	Publication Date	Title
FI892664A0 (fi)	1989-06-01	Menetelmä valmistaa säädetysti vapauttavia kiinteitä oraalisia annostusmuotoja, joiden vesipitoisuus on määritetty
IL87922A (en)	1993-07-08	Pharmaceutical compositions containing dihydropyridine derivatives in combination with metoprolol and process for their preparation
DE3853191D1 (de)	1995-04-06	Arzneimittelträger.
FI891338L (fi)	1989-09-25	Parannus menetelmään 2',3'-dideoksi-2',3'-didehydronukleosidien valmistamiseksi
HUT61196A (en)	1992-12-28	Process for producing pharmaceutical composition which may be dropped in the eye
FI891181L (fi)	1989-03-13	Foerfarande med hoeg renhetsgrad foer framstaellning av 4,6-diamino-1,3-benzendiol.
DE69001573D1 (de)	1993-06-17	Zusammensetzungen zur herstellung von in dosisformen aktiven vitaminen d3 sowie verfahren zur herstellung stabiler, in dosisformen aktiver vitamine d3 unter deren verwendung.
IT1215332B (it)	1990-02-08	Composizione farmaceutica contenente sulglicotide per la terapia dell'ulcera gastrica
FI860602A0 (fi)	1986-02-10	Anordning foer foersaettande i vertikal roerelse av en sits, isynnerhet en patientstol.
FR2592588B1 (fr)	1988-05-06	Mur d'escalade artificiel et procede de realisation de ce mur.
GB2196973B (en)	1991-01-02	Hydrophilic copolymer and the method for producing thereof
IT8921229A0 (it)	1989-07-19	Metodo per determinare la velocita' dei fili.
IT8882523A0 (it)	1988-03-08	Metodo per l'avanzamento del piede particolarmente nei pedali per velocipedi.
DE3776507D1 (de)	1992-03-12	Amphipathische polymerisierbare vinylmonomere, davon abgeleitete vinylharzteilchen und deren herstellung.
ES2052701T3 (es)	1994-07-16	Agente hipouricemico que contiene ponalrestat.
NO164341C (no)	1990-09-26	Anordning for fremstilling av metall-granulat i form av "naaler".
Jack	1986	Aspects of physisorption kinetics
Kuczmann	1988	Behaviour of PVC Powder Grains Produced Using Suspension Technology, in Processing
IT8720014A0 (it)	1987-04-07	Cristallino artificiale dell'occhio.
IT8719062A0 (it)	1987-01-13	Procedimento per la realizzazione di un contenitore con porzione superficiale rimovibile con sicurezza antifalsificazione, nonche' contenitore con porzione superficiale rimovibile
LV5266A3 (lv)	1993-10-10	Panemiens 1,3-aizvietoto tetrahidro-1h-tieno-(3,4-d)-imidazol-2-(3h)-on-4-4-iliden-pentanskabju esteru iegusanai
FR2557796B3 (fr)	1986-04-18	Procede et composition pour la conservation d'empreintes dentaires a base d'alginate.
IT8620470A0 (it)	1986-05-16	Procedimento per la polimerizzazione in sospensione acquosa di monomeri vinilici contenenti alogeno.
PL260789A2 (en)	1988-09-01	The method of manufacture of 3-replaced derivatives of 8-azo-2-oxa-bicycle-/4.2.0/octane-7-octone
ATE5723T1 (de)	1984-01-15	Substituierte pyrazinyl-1,2,4-oxadiazole, verfahren zur herstellung derselben und eine dieselben enthaltende pharmazeutische zubereitung.